title: Austrian Moderate Altitude Study (AMAS 2000): erythropoietic activity and Hb-O(2) affinity during a 3-week hiking holiday at moderate altitude in persons with metabolic syndrome.
abstract: Moderate altitude hypoxia (1500 to 2500 m) is known to stimulate erythropoiesis and to improve oxygen transport to tissue by a reduction of Hb-O(2) affinity. Whether this adaptation also occurs in tourists with metabolic syndrome has not yet been investigated sufficiently. Thus, we performed a prospective field study to measure erythropoietic parameters and oxygen transport properties in 24 male volunteers with metabolic syndrome during a 3- week holiday program at 1700 m consisting of four guided, individually adapted hiking tours per week. The following examinations were performed: baseline investigations at 500 m (T1); examinations at moderate altitude on day 1 (T2), day 4 (T3), day 9 (T4), and day 19 (T5); and postaltitude tests (T6) 7 to 10 days after return. On day 1 and day 19, a walk on a standardized hiking test route with oxygen saturation (SpO(2)) measure points was performed. Hemoglobin, packed cell volume, and red cell count showed changes over time, with higher values at T5 as compared to baseline. Reticulocyte count and erythropoietin (EPO) were increased at T2 and increased further until T5. EPO declined toward prealtitude values. P50-value (blood PO(2) at 50% hemoglobin oxygen saturation at actual pH) increased during the altitude sojourn (maximum increase at T5 by +0.40 kPa). At T5 all volunteers had a higher SpO(2) before, during, and at the end of the test route compared to T1. During adaptation to moderate altitude, persons with metabolic syndrome exhibit an increase in EPO and a rightward shift of the oxygen dissociation curve that is similar to healthy subjects.
authors.affiliation: University for Health Sciences, Medical Informatics and Technology Tyrol, Institute for Leisure,- Travel- and Alpine Medicine, Tyrol, Austria.
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Schobersberger
authors.forename: Sven
authors.initials: S
authors.lastname: Greie
authors.forename: Egon
authors.initials: E
authors.lastname: Humpeler
authors.forename: Markus
authors.initials: M
authors.lastname: Mittermayr
authors.forename: Dietmar
authors.initials: D
authors.lastname: Fries
authors.forename: Beatrix
authors.initials: B
authors.lastname: Schobersberger
authors.forename: Erika
authors.initials: E
authors.lastname: Artner-Dworzak
authors.forename: Walter
authors.initials: W
authors.lastname: Hasibeder
authors.forename: Anton
authors.initials: A
authors.lastname: Klingler
authors.forename: Hanns-Christian
authors.initials: HC
authors.lastname: Gunga
mesh_terms: D000064:Acclimatization; D000531:Altitude; D000704:Analysis of Variance; D001317:Austria; D004920:Erythropoiesis; D004921:Erythropoietin; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood* / Q000378:metabolism; D008875:Middle Aged; D010101:Oxygen Consumption; D011446:Prospective Studies; D017701:Reticulocyte Count; D013997:Time Factors
chemical_list: D006454:Hemoglobins; D004921:Erythropoietin